Cargando…
Leveraging Molecular and Immune-Based Therapies in Leptomeningeal Metastases
Leptomeningeal metastases represent an aggressive stage of cancer with few durable treatment options. Improved understanding of cancer biology, neoplastic reliance on oncogenic driver mutations, and complex immune system interactions have resulted in an explosion in cancer-directed therapy in the la...
Autores principales: | Wilcox, Jessica A., Boire, Adrienne A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829628/ https://www.ncbi.nlm.nih.gov/pubmed/36474108 http://dx.doi.org/10.1007/s40263-022-00975-5 |
Ejemplares similares
-
Leptomeningeal Metastases: New Opportunities in the Modern Era
por: Wilcox, Jessica A., et al.
Publicado: (2022) -
Palliation for all people: alleviating racial disparities in supportive care for brain metastases
por: Wilcox, Jessica A, et al.
Publicado: (2020) -
Advances in the diagnosis, evaluation, and management of leptomeningeal disease
por: Sener, Ugur, et al.
Publicado: (2021) -
Early Detection of Leptomeningeal Metastases Among Patients Undergoing Spinal Stereotactic Radiosurgery
por: Freret, Morgan E., et al.
Publicado: (2022) -
Molecular Interactions in the Development of Brain Metastases
por: Martinez, Nina, et al.
Publicado: (2013)